Glutamatergic Antipsychotic Drugs: A New Dawn in the Treatment of Schizophrenia?

Por Stone, James M.
Publicado em 2011

BrainMaps.org - Interactive High-Resolution Digital Brain Atlases and Virtual Microscopy

Por Mikula, Shawn, Stone, James M., Jones, Edward G.
Publicado em 2008

Drug models of schizophrenia

Por Steeds, Hannah, Carhart-Harris, Robin L., Stone, James M.
Publicado no Ther Adv Psychopharmacol (2015)

Internet-Enabled High-Resolution Brain Mapping and Virtual Microscopy

Por Mikula, Shawn, Trotts, Issac, Stone, James M., Jones, Edward G.
Publicado em 2007

Cortical Dopamine D(2)/D(3) Receptors Are a Common Site of Action for Antipsychotic Drugs—An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Liter...

Por Stone, James M., Davis, John M., Leucht, Stefan, Pilowsky, Lyn S.
Publicado em 2009

Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit—a mechanism of relevance to resistant depression?

Por Wong, Jing J., O’Daly, Owen, Mehta, Mitul A., Young, Allan H., Stone, James M.
Publicado no PeerJ (2016)

Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia

Por Egerton, Alice, Brugger, Stefan, Raffin, Marie, Barker, Gareth J, Lythgoe, David J, McGuire, Philip K, Stone, James M
Publicado em 2012

Speaker 3: John Krystal, USA

Por Krystal, John H., Anticevic, Alan, Yang, Genevieve, Driesen, Naomi, Cortes-Briones, Jose, Stone, James M., Wang, Xiao-Jing, Murray, John D.
Publicado no Int J Neuropsychopharmacol (2016)

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

Por Carhart-Harris, Robin L., Leech, Robert, Erritzoe, David, Williams, Tim M., Stone, James M., Evans, John, Sharp, David J., Feilding, Amanda, Wise, Richard G., Nutt, David J.
Publicado em 2013

Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation

Por Morgan, Celia J. A., Dodds, Chris M., Furby, Hannah, Pepper, Fiona, Fam, Johnson, Freeman, Tom P., Hughes, Emer, Doeller, Christian, King, John, Howes, Oliver, Stone, James M.
Publicado no Front Psychiatry (2014)

Disruption of Frontal Theta Coherence by Δ(9)-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms

Por Morrison, Paul D, Nottage, Judith, Stone, James M, Bhattacharyya, Sagnik, Tunstall, Nigel, Brenneisen, Rudolf, Holt, David, Wilson, Daniel, Sumich, Alex, McGuire, Philip, Murray, Robin M, Kapur, Shitij, ffytche, Dominic H
Publicado em 2011

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Por Carhart-Harris, Robin L., Erritzoe, David, Williams, Tim, Stone, James M., Reed, Laurence J., Colasanti, Alessandro, Tyacke, Robin J., Leech, Robert, Malizia, Andrea L., Murphy, Kevin, Hobden, Peter, Evans, John, Feilding, Amanda, Wise, Richard G., Nutt, David J.
Publicado em 2012

Relationship Between Brain Glutamate Levels and Clinical Outcome in Individuals at Ultra High Risk of Psychosis

Por Egerton, Alice, Stone, James M, Chaddock, Christopher A, Barker, Gareth J, Bonoldi, Ilaria, Howard, Rachel M, Merritt, Kate, Allen, Paul, Howes, Oliver D, Murray, Robin M, McLean, Mary A, Lythgoe, David J, O'Gorman, Ruth L, McGuire, Philip K
Publicado em 2014

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Por Bhattacharyya, Sagnik, Morrison, Paul D, Fusar-Poli, Paolo, Martin-Santos, Rocio, Borgwardt, Stefan, Winton-Brown, Toby, Nosarti, Chiara, O' Carroll, Colin M, Seal, Marc, Allen, Paul, Mehta, Mitul A, Stone, James M, Tunstall, Nigel, Giampietro, Vincent, Kapur, Shitij, Murray, Robin M, Zuardi, Antonio W, Crippa, José A, Atakan, Zerrin, McGuire, Philip K
Publicado em 2010